Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

REIFMAN, DR ANN

UEI: MLDBNPWS8ZY1

REIFMAN, DR ANN is a federal contractor, registered under UEI MLDBNPWS8ZY1. It has been awarded $645,000 in federal contracts. Primary work spans All Other Professional, Scientific, and Technical Services and Other Scientific and Technical Consulting Services. Top awarding agencies include Department Of Health And Human Services.

Contact Information

Registration and classification details

Registration

UEI Code

MLDBNPWS8ZY1

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

7

All time

Active

0

Currently performing

Completed

7

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with REIFMAN, DR ANN

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for REIFMAN, DR ANN

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in REIFMAN, DR ANN's top NAICS codes and agencies

NAICS: 541690
New
Federal
Senior Advisor 2 for Biological Therapeutics Development to act as External Oversight Committee (EOC) Subject Matter Expert (SME) Services.
Solicitation # 7571PSQ00013
Solicitation 7571PSQ00013 is a competitive request for quote for an executive-level Senior Advisor 2 to serve as a Subject Matter Expert (SME) for the NIH Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) and the HEAL Initiative. The selected contractor will act as a member of the External Oversight Committee (EOC), providing strategic guidance, programmatic reviews, and mentorship to advance the discovery and development of safe, non-addictive therapeutics for pain and nervous system conditions. The primary goal is to support the advancement of at least two novel therapeutics into clinical trials within five years. This is a small business set-aside under NAICS code 541690. The contract is structured as a fixed-price purchase order with a base period from November 5, 2026, to November 4, 2027, and two optional one-year extensions, for a total potential duration of three years. The government anticipates approximately 50 labor hours per year, with an option for an additional 50 hours, and may reimburse up to 2,000 dollars in annual travel expenses per consultant. Performance will primarily occur at the contractor's site, with occasional visits to Bethesda, Maryland. Award decisions will be based on best value, with technical qualifications—specifically professional expertise in pharmaceutical development and pain, educational credentials, and collaborative experience—weighted significantly more than price and past performance. Proposed key personnel must be employees of the quoter by the start of performance and are subject to a salary cap based on the Executive Schedule, Level II. All quotes must be submitted by November 3, 2026, and require active registration in the System for Award Management.
Omas Strategic Buying Center - Professional Services

POSTED

about 13 hours ago

DEADLINE

in 7 days
View Details